Barclays Maintains Overweight on Keurig Dr Pepper, Lowers Price Target to $32
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman maintains an Overweight rating on Keurig Dr Pepper (NASDAQ:KDP) but lowers the price target from $34 to $32.

March 12, 2024 | 10:07 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays maintains an Overweight rating on Keurig Dr Pepper but lowers the price target from $34 to $32.
While the reduction in price target could suggest a slightly less optimistic outlook on KDP's short-term price potential, the maintenance of an Overweight rating indicates continued confidence in the company's fundamentals. This mixed signal could lead to neutral short-term price movement as investors digest both the positive and negative aspects of the analyst's view.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100